Keywords: iom, drug, safety, panel, urged, seek, federally-mandated

US IoM drug safety panel urged to seek federally-mandated clinical trial registry

Article | 01 August 2005

Print This

The US Institute of Medicine's Committee on the Assessment of the US Drug Safety System (Marketletter June 20) has been urged ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in